Loading clinical trials...
Loading clinical trials...
A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to Hemostasis During Soft Tissue Open Surgeries
Conditions
Interventions
Fibrin Sealant (FS) Grifols
Surgicel®
Locations
25
United States
407
Florence, Alabama, United States
320, 322, 323
Pasadena, California, United States
404
Bridgeport, Connecticut, United States
321
Boynton Beach, Florida, United States
312
Rochester, Minnesota, United States
300
St Louis, Missouri, United States
Start Date
November 1, 2012
Primary Completion Date
April 1, 2015
Completion Date
June 1, 2015
Last Updated
February 23, 2017
Lead Sponsor
Grifols Biologicals, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions